CRIS Current Research Information System

CAMPANA, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.138
AS - Asia 7.692
EU - Europa 5.371
SA - Sud America 489
AF - Africa 452
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.054
SG - Singapore 2.203
CN - Cina 2.154
VN - Vietnam 1.881
GB - Regno Unito 1.508
DE - Germania 755
IT - Italia 707
SE - Svezia 616
HK - Hong Kong 570
IN - India 371
BR - Brasile 364
RU - Federazione Russa 327
UA - Ucraina 280
FR - Francia 238
KR - Corea 227
IE - Irlanda 223
CH - Svizzera 137
NL - Olanda 137
FI - Finlandia 129
ZA - Sudafrica 107
TG - Togo 104
CI - Costa d'Avorio 103
EE - Estonia 94
JP - Giappone 90
SC - Seychelles 67
AR - Argentina 66
CA - Canada 44
NG - Nigeria 43
ID - Indonesia 42
JO - Giordania 42
BE - Belgio 40
AT - Austria 34
BG - Bulgaria 34
MX - Messico 28
PL - Polonia 27
BD - Bangladesh 22
TR - Turchia 21
EC - Ecuador 19
IR - Iran 17
GR - Grecia 13
ES - Italia 12
CL - Cile 10
CO - Colombia 9
CZ - Repubblica Ceca 9
LB - Libano 8
LT - Lituania 8
MA - Marocco 8
RO - Romania 8
TW - Taiwan 8
EG - Egitto 7
PY - Paraguay 7
UZ - Uzbekistan 7
HR - Croazia 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
HU - Ungheria 5
IQ - Iraq 5
AL - Albania 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
MD - Moldavia 4
VE - Venezuela 4
MY - Malesia 3
TT - Trinidad e Tobago 3
AO - Angola 2
EU - Europa 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
LU - Lussemburgo 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DZ - Algeria 1
GF - Guiana Francese 1
GM - Gambi 1
GT - Guatemala 1
HT - Haiti 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
RE - Reunion 1
RS - Serbia 1
Totale 22.145
Salva come PNG Salva come JPEG
Città #
Singapore 1.399
Southend 1.341
Ashburn 914
Fairfield 859
Chandler 624
Hong Kong 565
Hefei 531
Ho Chi Minh City 396
Woodbridge 389
Seattle 387
Santa Clara 380
Houston 354
Wilmington 345
Hanoi 320
Princeton 316
Cambridge 287
Beijing 267
Dong Ket 262
Seoul 227
Dublin 220
Boardman 219
Ann Arbor 203
Jacksonville 174
Bologna 134
Los Angeles 126
Bern 125
Westminster 114
Lomé 104
Abidjan 103
Helsinki 101
Nanjing 101
Padova 96
Berlin 94
New York 92
Milan 88
Dallas 80
Tokyo 78
Redondo Beach 71
Jinan 59
Buffalo 58
Shenyang 52
Saint Petersburg 51
Shanghai 50
San Diego 49
Bengaluru 48
Frankfurt am Main 48
Nanchang 47
Changsha 46
Tianjin 45
Guangzhou 44
Abeokuta 42
Amman 42
São Paulo 42
Da Nang 41
Medford 41
Munich 41
Des Moines 38
Haiphong 37
Redmond 36
Mülheim 35
Sofia 34
Chicago 33
Turin 33
Biên Hòa 30
Bremen 29
Florence 29
Ha Long 29
Hebei 27
Jakarta 27
Brussels 26
Yubileyny 26
Ninh Bình 25
Tongling 24
Hải Dương 23
Quận Bình Thạnh 23
Zhengzhou 23
Phoenix 22
Wuhan 22
Falkenstein 20
Lappeenranta 20
Hangzhou 19
Jiaxing 19
Nuremberg 19
Bắc Giang 18
London 18
Bắc Ninh 17
Mahé 17
Thái Nguyên 17
Vienna 17
Warsaw 17
Washington 17
Atlanta 16
Brooklyn 16
Can Tho 16
Dearborn 16
Amsterdam 15
Fuzhou 15
Bühl 13
Haikou 13
Ningbo 13
Totale 14.331
Salva come PNG Salva come JPEG
Nome #
Metastatic 5-mm rectal neuroendocrine carcinoma. 608
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 365
Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading 246
A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours 217
Basis for treatment of functioning neuroendocrine tumours. 205
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. 204
Chromogranin A: is it a useful marker of neuroendocrine tumors? 203
Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT 201
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 200
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 200
Endocrine pancreatic tumors: factors correlated with survival. 199
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 192
A case of primary pancreatic lymphoma. 191
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 190
WHO 2010 classification of pancreatic endocrine tumors. Is the new always better than the old? 188
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 187
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 183
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 182
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. 180
68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease. 176
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study 176
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 172
Pancreatic involvement in systemic sarcoidosis. A case report. 171
Endocrine tumors of the ileum: factors correlated with survival. 169
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 168
The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay. 166
18f-fdg pet/ct for restaging gastric cancer after surgical resection 165
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review 164
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 161
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 160
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. 158
The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours. 155
Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT 155
Medical treatment of endocrine gastroenteropancreatic tumors. 151
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 151
Zollinger-Ellison syndrome. Diagnosis and therapy. 149
68Ga DOTANOC PET/CT Detects Primary Malignant Insulinoma. 148
G1/G2 discrimination of pNET with [68Ga]Ga-DOTANOC PET/CT quantitative parameters: is it feasible? 147
Water-related techniques in colonoscopy: the end justifies the means! 146
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 145
Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience. 144
Treatment of advanced gastro‐entero‐pancreatic neuro‐ endocrine tumors: A systematic review and network meta‐analysis of phase iii randomized controlled trials 144
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis 143
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study 142
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 142
Lubrication during colonoscopy: a forgotten factor. 140
Sedation during colonoscopy and the benefits of lubrication 138
Warm water and oil assistance in colonoscopy 138
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 138
Efficacy and Cost-Effectiveness of Immediate Surgery versus a Wait-and-See Strategy for Sporadic Nonfunctioning T1 Pancreatic Endocrine Neoplasms. 138
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time? 137
Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. 137
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients 135
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. 135
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis 134
Patient-reported outcomes in patients with endocrine tumors of the Ileum 133
Warm water and oil for the difficult colon 131
Maffucci syndrome with hemangioma of the liver 130
Multiple gastrinomas of the duodenum in a patient with sporadic Zollinger-Ellison syndrome. 130
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs 130
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 130
Multiple gastric endocrine tumors and gastrinomas of the duodenum in a patient with a ZES MEN I 129
Long-term survival in neuroendocrine tumors of the pancreas. 129
Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis 129
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 128
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 128
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors 127
Patient-reported outcomes in subjects with neuroendocrine tumors of the pancreas. 127
Autoimmune pancreatitis: the classification puzzle. 127
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours 127
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis 126
Warm water or oil-assisted colonoscopy: toward simpler examinations? 126
WHO-2010 and WHO-2000 classifications for pancreatic endocrine tumors. Is it time to change ? 126
Evaluation of patient-reported outcome in subjects treated medically for acute pancreatitis: a follow-up study 126
Treatment of Zollinger-Ellison Syndrome 126
Sedation on demand and lubrication during colonoscopy: should we change our mind ? 125
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 121
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations 121
Quality of life in chronic pancreatitis. 119
An Update on Appendiceal Neuroendocrine Tumors 118
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis 118
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? 118
[68Ga]Ga-DOTANOC PET/CT Derived Radiomic Features Can Discriminate Pancreatic Neuroendocrine Tumours from Accessory Spleens: Preliminary Results 118
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. 117
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 117
Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? 117
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. 116
Multimodal strategy in localized merkel cell carcinoma: Where are we and where are we heading? 116
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors 115
Siblings Diagnosed With Primary Neuroendocrine Tumor of the Left Hepatic Duct 114
[68Ga]Ga-DOTANOC PETICT & radiomics: Potential role in discriminating tumor grade in well-differentiated primary pancreatic neuroendocrine tumors 114
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 113
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 112
Lymph Node Ratio as a Prognostic Factor in Patients with Pancreatic Endocrine Tumours JOP 112
Landscape and future perspectives of immunotherapy in neuroendocrine neoplasia 112
68Ga-DOTA-NOC and 18F-DOPA PET in the evaluation of patients with neuroendocrine tumours. 111
The 3-Dimensional-Computed Tomography Texture Is Useful to Predict Pancreatic Neuroendocrine Tumor Grading 111
Surgical treatment of non-functioning pancreatic islet cell tumors 109
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 109
Neuroendocrine Tumours with Secondary Liver Lesions 108
Totale 15.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.309 0 0 0 0 0 51 35 187 195 104 127 610
2021/20222.869 344 83 148 174 238 131 50 216 117 132 833 403
2022/20233.048 296 400 131 351 234 245 95 181 530 97 242 246
2023/2024844 87 151 72 78 71 175 39 47 23 32 31 38
2024/20253.934 154 555 347 264 649 221 301 113 59 257 207 807
2025/20265.802 1.087 1.619 885 762 1.023 426 0 0 0 0 0 0
Totale 22.574